Latest News

Making progress to make Autologous Hematopoietic Stem Cell Treatment (aHSCT) an available treatment option in NZ for MS

September 14, 2022 | Advocacy, Treatments

Autologous Hematopoietic Stem Cell Treatment (aHSCT) is an intense chemotherapy treatment which aims to wipe out harmful immune cells and rebuild the immune system. aHSCT is a life-improving treatment halting the disease and disability in its tracks. A person receiving […]


Addressing the unmet need

September 14, 2022 | Advocacy, Progressive, Treatments

Currently, only approximately 1900 of the over 4130 New Zealanders diagnosed with MS are able to access funded Disease Modifying Therapies (DMTs). In particular, those with progressive forms of MS, Secondary (SPMS) and Primary Progressive MS (PPMS), have extremely limited […]


aHSCT in the news: We’re fed up waiting for it to be made available here

July 26, 2022 | Advocacy, Life with MS, Media, Treatments

A 10,000-strong petition asking Health New Zealand to extend “game-changing” stem cell treatment to multiple sclerosis (MS) patients is set to be delivered to Parliament. The petition started by Aucklander Joan Perry​, whose daughter Anne Besley​ has MS, calls for autologous haematopoietic […]


aHSCT in the media – Bronwyn Hutchinson interview on Today FM

July 26, 2022 | Advocacy, Life with MS, Media, Treatments

Listen how Bronwyn struggled with every day life, couldn’t look after her children or hold a book, and how it led her to raise $100,000 and head to Mexico for life changing treatment, aHSCT. The interview was aired this morning […]


Media Release: Government urged to “get a move on” and approve cost-effective, proven, stem cell treatment for Multiple Sclerosis

July 26, 2022 | Advocacy, Life with MS, Media, Treatments

Tuesday 26th July 2022 A private petition is being delivered to the steps of parliament at lunchtime today – calling for the government to green-light a treatment, readily available overseas, which is delivering remarkable improvements to the health of many […]